These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5790046)

  • 21. A comparison of phenformin and metformin in the treatment of maturity onset diabetes.
    Cairns SA; Shalet S; Marshall AJ; Hartog M
    Diabete Metab; 1977 Sep; 3(3):183-8. PubMed ID: 913750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Various therapeutic prerogatives of phenethylbiguanide in diabete mellitus. Effect of the drug on body weight, blood cholesterol, fibrinolysis, and blood lactic acid].
    Previato G; Barbui T; Guarnieri GF; Di Luzio V; Padovan D
    Clin Ter; 1969 Jul; 50(1):27-36. PubMed ID: 5386586
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus.
    Butterfield WJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):724-33. PubMed ID: 5242146
    [No Abstract]   [Full Text] [Related]  

  • 24. PHENFORMIN, SERUM LIPIDS AND DIABETES MELLITUS.
    SCHWARTZ MJ; MIRSKY S; SCHAEFER LE
    Lancet; 1965 May; 1(7392):959. PubMed ID: 14275725
    [No Abstract]   [Full Text] [Related]  

  • 25. [Influence of a new oral hypoglycemic product (glibenclamide-phenformin) on some aspects of lipid metabolism].
    Ceruso D; Squadrito G; Emanuele M; Quartarone M; Bellinghieri G
    Boll Soc Ital Biol Sper; 1973 Nov; 49(22):1285-9. PubMed ID: 4212680
    [No Abstract]   [Full Text] [Related]  

  • 26. Experience with phenformin as an oral antidiabetic agent.
    Drury MI; Timoney FJ
    J Ir Med Assoc; 1970 Jan; 63(391):13-7. PubMed ID: 4903812
    [No Abstract]   [Full Text] [Related]  

  • 27. A lipid and lipoprotein profile of treated and untreated diabetics.
    Billimoria JD; Isaacs AJ; Melki K
    Ann Clin Biochem; 1976 Jan; 13(1):315-21. PubMed ID: 175734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
    Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
    Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of biguanide treatment of body-weight in diabetics and non-diabetics.
    Duncan LJ; Clarke BF; Munro JF
    Postgrad Med J; 1969 May; 45():13-9. PubMed ID: 5364310
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasmatic lipid pattern in the obese: total lipids, triglycerides, phospholipids, alpha and beta lipoproteic cholesterol and single NEFA (C16-C18)].
    Bertolini AM; Santagostino A
    Minerva Med; 1973 Apr; 64(27):1429-37. PubMed ID: 4708214
    [No Abstract]   [Full Text] [Related]  

  • 31. Phenformin in human obesity.
    Roginsky MS; Sandler J
    Ann N Y Acad Sci; 1968 Mar; 148(3):892-6. PubMed ID: 4872313
    [No Abstract]   [Full Text] [Related]  

  • 32. [The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
    Vogelberg KH; Cicmir I; Heggen ME
    Arzneimittelforschung; 1980; 30(4):683-5. PubMed ID: 7190412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients].
    Beyer J; Ewald W; Kunkel W; Wolf E; Schöffling K
    Dtsch Med Wochenschr; 1971 Apr; 96(17):728-33. PubMed ID: 5552854
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood lipids and glucose tolerance in 100 patients with arteriosclerotic occlusions in the lower extremities].
    Beyrer K; May R; Sailer S
    Wien Klin Wochenschr; 1968 May; 80(20):392-4. PubMed ID: 5728030
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relationships between body weight and plasma lipids in hyperlipaemic patients (author's transl)].
    Lisch HJ; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1974 Feb; 86(4):97-9. PubMed ID: 4439946
    [No Abstract]   [Full Text] [Related]  

  • 36. [A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis].
    Dil'man VM; Riabov SI; Tsyrlina EV; Kirsanov AI; Kovaleva IG
    Vopr Onkol; 1972; 18(2):84-6. PubMed ID: 5012922
    [No Abstract]   [Full Text] [Related]  

  • 37. Gout and hyperlipidaemia. Effect of overweight on the levels of circulating lipids.
    Rondier J; Truffert J; le Gô A; Cayla J; Hila A; de Gennes JL; Delbarre F
    Ann Clin Res; 1977 Aug; 9(4):239-45. PubMed ID: 616208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes].
    Gervasini A
    Minerva Med; 1974 Oct; 65(73):3835-42. PubMed ID: 4214284
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical evaluation of a new hypolipidemic drug, CIBA 13,437-Su.
    Hartmann G; Forster G
    J Atheroscler Res; 1969; 10(2):235-46. PubMed ID: 5381845
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of prednisone on serum lipids in children with rheumatic fever.
    Werbin B; Heldenberg D; Burstein Y; Levtow O; Tamir I
    Isr J Med Sci; 1974 May; 10(5):482-5. PubMed ID: 4413081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.